Solid lipid nanoparticles combine the biocompatibility of lipids with the structural advantages of nanoparticle formulations
This innovative base supports the medication's rapid uptake into the bloodstream, bypassing the gastrointestinal tract and optimizing its efficacy
They regulate blood sugar and appetite by mimicking the action of the naturally occurring gut hormone GLP-1, a modulator of insulin secretion, glucagon, stomach emptying, and satiety signalling
The principle is the same for both: start low, increase slowly, let your body adapt
In psoriasis, GLP-1 RAs, particularly liraglutide, have been associated with improvements in the Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI), especially among patients with T2D
Safety and Quality: VIOS maintains strict quality and safety standards in producing GLP-1